24 October, 2024
Translink Corporate Finance in the United Kingdom advised shareholders of Riverside Medical Packaging, a leading supplier of sterilisation packaging systems and services on the sale to Sterimed, a world leader in medical packaging.
Specialists in complex medical packaging solutions, Riverside has over the past 45 years, become a leading UK provider of tailored contract packing services for the medical device industry, housing 12 cleanrooms (3 Class 8 & 9 Class 7) with significant thermoforming production capabilities. Under the trade name Aseptic Medical Devices (AMD), the company has also successfully developed multi-packed syringes and medical devices in a format designed exclusively for the production of aseptically manufactured parenterals for hospital pharmacists and compounders.
Built on a foundation of excellence, Riverside is recognised for the high performance of its products and services, thanks to its dedicated and highly skilled team of 200 people in Derby. This acquisition is complementary to Sterimed’s existing operations and allows the group to further strengthen its service offering to medical device manufacturers. It also accelerates its strategic growth into pharma applications.
The Management team of Riverside, led by the Managing Director Matthew Roe, will stay in place and join the entrepreneurial journey of Sterimed. David Shaw, founder of the company, will stay as a Director of Riverside and will join the Sterimed core entrepreneurs’ team by becoming a shareholder of the Sterimed group alongside the existing management team, families, and financial partners of Sterimed.
Thibaut Hyvernat, President and CEO at Sterimed said, “I am delighted to welcome a wonderful new team, and a wonderful business, within Sterimed. All the preparatory works and discussions have taken place in such a constructive spirit that this alliance became obvious for everybody very quickly, making all of us sure of its relevancy. This is another big step forward in Sterimed’s development strategy, bringing a lot of new cross-fertilisation opportunities for Riverside Medical and a number of current Sterimed sites and businesses.”
David Shaw, founder of Riverside said, “We are thrilled to have completed this transaction and to now be part of the Sterimed Group. Over its 45-year history, Riverside has grown into one of the UK’s leading medical packaging suppliers. Our success has been the result of a dedicated and committed workforce, long term vision and innovation. With the synergies, opportunities and security that will now arise from being part of the Sterimed family of companies, I am confident that the future prosperity of Riverside is assured, and our customers will benefit hugely from the wider variety of services Riverside will now be able to offer.”
Matthew Roe, who will remain as Managing Director of Riverside said, “Myself, my management team, and our proficient and experienced workforce are thrilled to be joining the Sterimed Group. The synergies for cooperation and expansion within the group will accelerate our growth and cement our position as one of the leading providers to the medical device industry. The partnership with these prestigious medical packaging companies will give us a global presence and create exciting new opportunities.”
Sally Saunders, Partner at Translink UK commented, “It has been a privilege to work with the shareholders of Riverside Medical Packaging. The business has achieved significant growth through continued innovation and building trusted customer relationships, becoming a market-leading player and we are excited to see the huge growth potential in joining forces with the Sterimed group.”
Contact our Team Members advising in this transaction:
Translink Corporate Finance is a world leader in cross-border mid-market M&A advisory services, specialising in transactions ranging from €10M to €250M. Established in 1972, with over five decades of experience, we get the deal done. We are a trusted global group with over 400 experts worldwide, and a proven track record with long-standing clients and deep sector specific knowledge. At Translink Corporate Finance, we are easy to approach, and our core ethos revolves around the pursuit of sustainable value creation for our clients – whose best interests always come first.
Translink Corporate Finance in the UK has seven offices in Birmingham, Edinburgh, Leeds, Leicester, London, Nottingham and Sheffield. The highly experienced team comprises of 30 M&A professionals, including ten partners has a successful track-record of completing domestic and international M&A transactions across a variety of sectors.
About Translink Corporate Finance in France
Acting for over 50 years, Translink Corporate Finance is a global leader in SmidCap M&A (valuations ranging from €10 to 250 million), bringing together over 400 investment bankers in more than 35 countries. In France, the team consists of more than 20 professionals dedicated to M&A and financing operations, possessing sector-specific expertise in TMT, business services, healthcare, industrials, and energy. www.translinkcf.fr/en/